Markets
Stock market risk
(CSA Archives/Getty Images)

Goldman: “We see three main areas of risk” for the market

If fresh data on the state of the US economy starts to confirm slowdown fears, buckle up.

As the markets continue to struggle — though we’re still just 3% below the all-time closing high for the S&P 500 — it’s always worth stepping back to assess the major sticking points for stocks at the moment.

Goldman Sachs’ London-based team of global market analysts tucked a nice succinct chunk of that sort of perspective into the weekly note they published early Monday, saying they see three main areas of risk.”

The first, they say, is to be found in the relationship between sky-high valuations — the S&P 500 forward price-to-earnings ratio is still just below 23x — in the context of an economy that may be slowing.

We say “may be” because we’ve been sort of flying blind for weeks, as the market’s regular data diet was disrupted due to the US government shutdown. Now that the shutdown is over, factual updates on the US economy will recommence over the next few days, with the US monthly jobs report for September due Thursday. If the fresh data starts to confirm slowdown fears, buckle up.

“Given high valuations in equity markets, any disappointment in economic growth is likely to lead to a sell-off,” Goldman analysts wrote.

The second key risk Goldman spotlighted hinges on AI and whether the surge in spending on data centers, especially by so-called hyperscalers like Meta, Amazon, Oracle, Microsoft, and Alphabet, will ultimately prove profitable.

That’s a big deal for the markets — Goldman notes that the five largest US tech firms make up 17% of total global stock market equity value. In other words, if they go down, the markets go down. And whether or not they go down depends largely on whether this massive AI bet will turn out profitably, the analysts wrote: “Any signs of revenue weakness, or declining returns on the back of higher capex spending, would likely drive a correction.”

The third potential trip wire for stocks, they said, can be found by tracking where these companies are increasingly planning to get the money to pay for big AI build-outs — that is, in the corporate bond market.

If yields — or the price of borrowing — in those markets start to climb, it could disrupt the positive picture market bulls have painted of the AI data center boom. That picture is currently one in which massive capex spending leads almost hydraulically to higher future profits and therefore higher stock prices.

But higher borrowing costs means the market would be forced to consider how the higher financial cost for data centers could compress those future profits, or potentially dissuade some build-outs altogether, which would then, in theory, weigh on the broader economy. Under such a scenario, there would be few places to shelter from the market storm, Goldman analysts said.

“Any signs of a broadening weakness in the private credit market, or funding for governments, could be the trigger for a renewed sell-off in sovereign yields and spreads,” Goldman analysts wrote, adding, “This could have the potential to push all asset classes down together.”

Read More: How speculative stocks lost one-third of their value in the past month

More Markets

See all Markets
markets

Nike craters after issuing weak revenue guidance

Sportswear kingpin Nike is tumbling on Wednesday morning after saying it doesn’t expect to grow sales this year.

On its fiscal Q3 earnings call, management said that revenue is expected to drop 2% to 4% in the current quarter, and that overall they “expect revenues to be down low-single-digits versus the prior year, with gains in North America offset by declines in Greater China.” That's a disappointment to analysts, who were anticipating 2% growth in Q4, and even more in the latter stages of the year, per Bloomberg.

Nike’s Q3 sales in China — where the company earns about 15% of its revenue — fell 7% to $1.62 billion. The company had issued weak guidance for this quarter considering continued softness in the region. That’s its seventh straight quarter of sales declines in the market. While this quarter’s was decline was less than feared, management warned that more pain is in the offing.

Nike’s turnaround effort “is complex work, and parts of it are taking longer than I'd like,” said CEO Elliott Hill.

Nike’s fiscal Q3 results (the three months ended February) were solid at the headline level:

  • Earnings of $0.35 per share, comfortably above the Wall Street consensus of $0.29 per share compiled by FactSet.

  • $11.28 billion in total revenue, roughly in line with the $11.26 billion estimate.

But the gloomy sales outlook has Wall Street analysts souring on the stock:

  • JPMorgan downgraded the shares to “neutral” from “overweight” and cut its price target to $52 from $86.

  • Citi reduced its target price to $53 from $65,

  • Stifel lowered its price target to $56 from $65,

  • Truist reduced its price target to $57 from $69, and

  • Barclays cut its target price to $67 from $73.

Nike shares are trading near decade lows this month, as tariffs continue to weigh on profits and shipping costs rise amid the war with Iran. As of Tuesday’s close, the stock was down 17% year to date.

Oil-sensitive travel stocks pop following Iran state media reporting on potential war resolution

Travel stocks are surging on Tuesday as oil prices fall following reports from Iranian state media that President Masoud Pezeshkian said the country has the necessary will to end this war, but would only do so with guarantees that prevent the recurrence of aggression.

The war has sent oil prices and refining margins surging this month, causing airlines and cruise lines to cut profit forecasts despite reported high demand.

Following Tuesday’s update, shares of the big four US airlines (Delta Air Lines, United Airlines, American Airlines, and Southwest Airlines) all climbed, along with smaller rivals including JetBlue. US airlines have stopped fuel hedging in recent years, increasing their exposure to upward swings in oil prices.

Cruise stocks also rallied, with Carnival and Norwegian up more than 6% and Royal Caribbean up about 5%.

markets

The FDA is expected to lift restrictions on certain peptides, the NYT reports

The Food and Drug Administration is expected to lift restrictions on certain peptides, allowing the experimental, often injectable substances to be sold by compounding pharmacies, The New York Times reported Tuesday.

The potential move was previously reported by The Wall Street Journal, and teased by Health Secretary Robert F. Kennedy Jr. on the “Joe Rogan Experience” podcast in late February.

Peptides have boomed in popularity recently, with search interest for “peptides” surpassing “ozempic” this month. Many of them are currently understudied and not approved for human use, a rule consumers are able to bypass by purchasing them from suppliers that sell them for, ostensibly, research purposes only.

As reports of the FDA changing its stance of peptides mount, consumer health companies like Hims & Hers and Superpower have been getting ready to roll out their peptide offerings as soon as they get the FDA's blessing.

Peptides have boomed in popularity recently, with search interest for “peptides” surpassing “ozempic” this month. Many of them are currently understudied and not approved for human use, a rule consumers are able to bypass by purchasing them from suppliers that sell them for, ostensibly, research purposes only.

As reports of the FDA changing its stance of peptides mount, consumer health companies like Hims & Hers and Superpower have been getting ready to roll out their peptide offerings as soon as they get the FDA's blessing.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, Robinhood Derivatives, LLC, or Robinhood Money, LLC. Futures and event contracts are offered through Robinhood Derivatives, LLC.